跳至主要内容
临床试验/NCT05642390
NCT05642390终止不适用

Prospective Observational Study About SEBBIN Silicone Gel-filled INTEGRITY Mammary Implants

Groupe SEBBIN1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2022年3月11日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Groupe SEBBIN
入组人数
5
试验地点
1
主要终点
Complication rate

研究概览

简要总结

This study is part of the clinical evaluation of SEBBIN silicone gel-filled INTEGRITY implants, included in the technical file of the device. The aim of the study is to gather additional data about the safety and effectiveness of the device.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • The patient is at least 18-year-old.
  • The patient is a woman.
  • The patient was prescribed with a surgery for a breast augmentation or reconstruction, unilaterally or bilaterally with silicone gel-filled SEBBIN INTEGRITY mammary implants.
  • The patient has been informed of the study, has read the patient information letter and provided consent in writing.

排除标准

  • The patient is pregnant or breastfeeding.
  • The patient has silicone implants somewhere else than in the breast.
  • The patient was diagnosed with one of the following pathologies:
  • Systemic lupus erythematous, Sjogren syndrome, scleroderma, polymyositis, or any other connective tissue disease.
  • Rheumatoid arthritis, crystalline arthritis, infectious arthritis, spondyloarthropathies, or any other inflammatory arthritic disease.
  • Arthritis, fibromyalgia, chronic fatigue syndrome, or any other mechanic or degenerative non-inflammatory rheumatic disease.
  • History of implant-associated anaplastic large cell lymphoma (BIA-ALCL).
  • Symptomatic autoimmune disease.
  • The patient has a pathology that could delay healing (does not apply to the reconstruction group).
  • The patient has cancer (does not apply to the reconstruction group).
  • The patient has anatomical or physiological conditions that could lead to postoperative complications.

结局指标

主要结局

Complication rate

时间窗: At 10 years of follow-up

次要结局

未报告次要终点

研究者

发起方
Groupe SEBBIN
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验